Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement.
AuthorsHolmes, Sarah J
Whitehouse, Richard W
O'Halloran, Domhnall J
Adams, Judith E
Shalet, Stephen M
AffiliationDepartment of Endocrinology, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractOBJECTIVE: Growth hormone replacement of adults with childhood onset GH deficiency results in an increase in bone mineral density (BMD) after 6-12 months of GH replacement. By measuring BMD 12 months after discontinuation of GH replacement we aimed to investigate whether there is an effect of GH replacement on BMD persisting after GH has been withdrawn. DESIGN: BMD was measured 13 +/- 1 (mean +/- SE, range 11-16) months after discontinuation of GH replacement. PATIENTS: Ten adults, age 23.2 +/- 1.4 (range 18.8-32.4) years, with childhood onset isolated GH deficiency (2 idiopathic, 8 irradiation induced) who had previously completed a study of the effect of 12 months of GH replacement on BMD. MEASUREMENTS: Forearm cortical bone mineral content (BMC) was measured using single-photon absorptiometry at the proximal site of the distal forearm. Forearm integral BMC at the ultradistal site of the forearm and bone width at both proximal and ultradistal sites of the distal forearm were measured by the same technique. Vertebral trabecular BMD was measured using quantitative computed tomography. RESULTS: Forearm cortical BMC was significantly greater than that measured at the time of discontinuation of GH (1.48 +/- 0.04 vs 1.44 +/- 0.05 g/cm). There was no significant change in forearm integral BMC or in vertebral trabecular BMD after discontinuation of GH. There was no significant change in bone width at proximal and ultradistal sites of the distal forearm after discontinuation of GH. CONCLUSION: After discontinuation of GH replacement the further increase in forearm cortical bone mineral content without a significant increase in forearm bone width suggests that the increase in cortical bone mineral content is due to a persisting effect of previous GH replacement, and not to further spontaneous attainment of bone mass before peak bone mass is reached. These findings emphasize the importance of continuing to monitor bone mass after the stimulus to increase bone turnover has been withdrawn.
CitationFurther increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. 1995, 42 (1):3-7 Clin. Endocrinol
- Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency.
- Authors: Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM
- Issue date: 1995 Jun
- Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
- Authors: Rahim A, Holmes SJ, Adams JE, Shalet SM
- Issue date: 1998 Apr
- Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency.
- Authors: O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM
- Issue date: 1993 May
- Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.
- Authors: Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M
- Issue date: 1992 Jan
- Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
- Authors: Valk NK, Erdtsieck RJ, Algra D, Lamberts SW, Pols HA
- Issue date: 1995 Sep